Myers JD, Taylor WJ. An estimation of portal venous pressure by occlusive catheterization of a hepatic venule. J Clin Invest. 1951;30:662–3.
Lu Q, Leong S, Lee KA, et al. Hepatic venous- portal gradient (HVPG) measurement: pearls and pitfalls. Br J Radiol. 2021;94:20210061.
Article PubMed PubMed Central Google Scholar
Tetangco EP, Silva RG, Lerma EV. Portal hypertension: etiology, evaluation, and management. Review Dis Mon. 2016;62:411–26.
Kulkarni AV, Rabiee A, Mohanty A. Management of portal hypertension. J Clin Exp Hepatol. 2022;12:1184–99.
Article CAS PubMed PubMed Central Google Scholar
De Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–74.
Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65:310–35.
Albilllos A, Garcia-Tsao G. Classification of cirrhosis: the clinical use of HVPG measurements. Dis Markers. 2011;31:121–8.
Article PubMed PubMed Central Google Scholar
Feu F, Garcia-Pagan JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–9.
Article CAS PubMed Google Scholar
Villanueva C, Balanzo J, Novella MT, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996;334:1624–9.
Article CAS PubMed Google Scholar
Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001;345:647–55.
Article CAS PubMed Google Scholar
McCormick PA, Patch D, Greenslade L, et al. Clinical vs hemodynamic response to drugs in portal hypertension. J Hepatol. 1998;28:1015–9.
Article CAS PubMed Google Scholar
Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology. 2002;123:1013–9.
Article CAS PubMed Google Scholar
Fukunaga M. Diagnostic significance of hepatic venography and retrograde portography in portal hypertension. Kanzo. 1987;28:939–48.
Yoshiji H. Portal hypertension: advances in clinical practice from the Baveno VII consensus statement. Kanzo. 2024;65:49–57.
De Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–52.
Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280–2.
Suk KT. Hepatic venous pressure gradient: clinical use in chronic liver disease. Clin Mol Hepatol. 2014;20:6–14.
Article PubMed PubMed Central Google Scholar
Yamamoto Y, Kawada N, Jogo A, et al. Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein. Gut. 2021;70:1199–201.
Perello A, Escorsell A, Bru C, Gilabert R, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999;30:1393–7.
Article CAS PubMed Google Scholar
Bochnakova T. Hepatic venous pressure gradient. Clin Liver Dis. 2021;17:144–8.
Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol. 2002;37:960–4.
Article CAS PubMed Google Scholar
Ma J, Gong X, Luo J, et al. Impact of intrahepatic venovenous shunt on hepatic venous pressure gradient measurement. J Vasc Interv Radiol. 2020;31:2081–8.
Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep. 2017;5:79–89.
Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–8.
Article CAS PubMed Google Scholar
Berzigotti A, Seijo S, Reverter E, et al. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141–55.
Article CAS PubMed Google Scholar
Laleman W, Vanderschueren E, Van der Merwe S, et al. The use of endoscopic ultrasound in the diagnosis and management of portal hypertension. Best Pract Res Clin Gastroenterol. 2022;101811:60–1.
Bassegoda O, Olivas P, Turco L, et al. Decompensation in advanced nonalcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels than in patients with viral disease. Clin Gastroenterol Hepatol. 2022;20:2276–86.
Article CAS PubMed Google Scholar
Huang JY, Samarasena JB, Tsujino T, et al. EUS-guided portale pressure gradient measurement with a novel 25-gauge needle device versus transjugular approach: a comparison animal study. Gastrointest Endosc. 2016;84:358–62.
Choi AY, Chang KJ, Samarasena JB, Lee JG, et al. Endoscopic ultrasound-guided porto systemic pressure gradient measurement correlates with histological hepatic fibrosis. Dig Dis Sci. 2022;67:5685–92.
Hajifathalian K, Westerveld D, Kaplan A, et al. Simultaneous EUS-guided portosystemic pressure measurement and liver biopsy sampling correlate with clinically meaningful outcomes. Gastrointest Endosc. 2022;95:703–10.
Choi AY, Kolb J, Shah S, Chahine A, et al. Endoscopic ultrasound-guided portal pressure gradient with liver biopsy: 6 years of endo-hepatology in practice. J Gastroenterol Hepatol. 2022;37:1373–9.
Zhang W, Peng C, Zhang S, et al. EUS-guided portal pressure gradient measurement in patients with acute or subacute portal hypertension. Gastrointest Endosc. 2021;93:565–72.
Chikamori F, Kuniyoshi N, Okamoto H, et al. Systemic hemodynamic derangement in portal hypertension. Kanzo. 2012;53:316–23.
Chikamori F, Sharma N, Ito S, et al. Stepwise partial splenic embolization for portal hypertension based on a new concept: splanchnic caput medusae. Radiol Case Rep. 2020;16:564–70.
Article PubMed PubMed Central Google Scholar
Henriksen JH, Møller S. Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand Cardiovasc J. 2009;43:218–25.
Article CAS PubMed Google Scholar
Meng HC, Lin HC, Tsai YT, et al. Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis. J Gastroenterol Hepatol. 1994;9:148–53.
留言 (0)